Integer Holdings Corporation logo

Integer Holdings Corporation (ITGR)

Market Open
2 Sep, 14:24
NYSE NYSE
$
125. 42
+0.03
+0.0239%
$
4.26B Market Cap
43.8 P/E Ratio
- Div Yield
118,487 Volume
5.31 Eps
$ 125.39
Previous Close
Add Transaction
Day Range
125.39 125.45
Year Range
62 126.14
Want to track ITGR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

ITGR trading today higher at $125.42, an increase of 0.0239% from yesterday's close, completing a monthly increase of 0.2558% or $0.32. Over the past 12 months, ITGR stock gained 60.0357%.
ITGR is not paying dividends to its shareholders.
The last earnings report, released on Apr 22, 2026, exceeded the consensus estimates by 0%. On average, the company has fell short of earnings expectations by -0.5267%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 4 different exchanges and in various currencies, with the primary listing on NYSE (USD).

ITGR Chart

People also search for

TTC
The Toro Company
$ 98.91
+0.9698%
TKR
Timken Co.
$ 120.53
+1.2134%
Oscar Health, Inc.
$ 29.91
+0.2951%
Hims & Hers Health, Inc.
$ 29.06
+2.18%
Hinge Health Inc.
$ 91.4
+1.5329%
Integer Holdings Q2 Earnings & Revenues Top Estimates, Margins Decline

Integer Holdings Q2 Earnings & Revenues Top Estimates, Margins Decline

ITGR beats Q2 earnings and revenue estimates, but sales and margins decrease as product headwinds persist ahead of its $5.7B KKR deal.

Zacks | 3 weeks ago
Compared to Estimates, Integer (ITGR) Q2 Earnings: A Look at Key Metrics

Compared to Estimates, Integer (ITGR) Q2 Earnings: A Look at Key Metrics

The headline numbers for Integer (ITGR) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Zacks | 4 weeks ago
Integer (ITGR) Q2 Earnings and Revenues Top Estimates

Integer (ITGR) Q2 Earnings and Revenues Top Estimates

Integer (ITGR) came out with quarterly earnings of $1.6 per share, beating the Zacks Consensus Estimate of $1.38 per share. This compares to earnings of $1.55 per share a year ago.

Zacks | 1 month ago

Integer Holdings Corporation Investors

Name Quantity Cost Value Profit ($) Gain (%)
Curtis Ellergodt
Curtis Ellergodt Rothschild Investment LLC
59 $5,709.74 $7,400.96 $1,691.22 29.62%
JD
Jim Dushek HARBOUR INVESTMENTS Inc.
24 $2,199.2 $3,010.08 $810.88 36.87%
IH
Isaac Haas Hbk Investments LP
155,186 $14.5M $19.44M $4.94M 34.04%
SN
Stephanie Nee HARBOR CAPITAL ADVISORS Inc.
128 $12,983.99 $16,034.56 $3,050.57 23.49%
BG
Bart Gancher Intech Investment Management LLC
8,300 $960,399 $1.04M $79,176 8.24%

Integer Holdings Corporation Analysts

Name Quantity Cost Value Profit ($) Gain (%)
KH
Keith Hinton Freedom Capital Markets
478.32 $46,186.31 $60,004.89 $13,818.58 29.92%

Integer Holdings Corporation (ITGR) FAQ

What is the stock price today?

The current price is $125.42.

On which exchange is it traded?

Integer Holdings Corporation is listed on NYSE.

What is its stock symbol?

The ticker symbol is ITGR.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 4.26B.

Has Integer Holdings Corporation ever had a stock split?

No, there has never been a stock split.

Integer Holdings Corporation Profile

Health Care Equipment & Supplies Industry
Healthcare Sector
Payman Khales CEO
NYSE Exchange
45826H109 CUSIP
US Country
11,000 Employees
- Last Dividend
- Last Split
29 Sep 2000 IPO Date

Overview

Integer Holdings Corporation is a leading medical device outsource manufacturer offering a wide range of products and services across the globe, including the United States, Puerto Rico, Costa Rica, and other international markets. The company, founded in 1970 and headquartered in Plano, Texas, operates through two primary segments: Medical and Non-Medical. It caters to the needs of multi-national original equipment manufacturers (OEMs) and their affiliated subsidiaries, particularly in the areas of cardiac rhythm management, neuromodulation, orthopedics, vascular, advanced surgical, and portable medical markets. Integer Holdings Corporation's offerings are essential in a variety of medical procedures such as interventional cardiology, electrophysiology, and surgeries involving orthopedics, offering cutting-edge solutions that enhance patient care and outcomes.

Products and Services

Integer Holdings Corporation provides a diverse portfolio of products and services across various medical fields:

  • Cardiovascular and Cardiac Rhythm Management: Products include implantable pacemakers, cardioverter defibrillators, insertable cardiac monitors, pacing and defibrillation leads, heart failure therapies, and more, catering to interventional cardiology and structural heart procedures.
  • Neuromodulation: Offers implantable spinal cord stimulators for managing chronic pain and other conditions through neurostimulation.
  • Vascular Access and Peripheral Vascular: Provides solutions for hemodialysis, infusion therapy, and peripheral vascular interventions, improving patient outcomes in these critical areas.
  • Non-Vascular Interventions: Supplies products for urology, gastroenterology, and non-vascular procedures, ensuring a broad coverage of medical needs.
  • Energy Solutions: Offers customized battery power and management systems for medical devices, alongside battery solutions for the energy, military, and environmental markets, highlighting the company's expertise beyond the medical field.
  • Surgical Instruments and Components: Supplies a variety of devices and components for general surgery, orthopedics, laparoscopic, and arthroscopic procedures, including harmonic scalpels, shaver blades, biopsy probes, and instruments used in hip, knee, and spine surgeries.
  • Advanced Surgical and Portable Medical Devices: Provides cutting-edge products for advanced surgical procedures and portable medical devices, such as wound dressings, GERD treatment components, and phacoemulsification needles, proving Integer's commitment to innovation in surgery and patient care.

Contact Information

Address: 5830 Granite Parkway
Phone: 214 618 5243